Copyright medicaldialogues
A new meta-analysis published in BMC Nephrology reports that there is no significant difference in overall survival between patients undergoing peritoneal dialysis (PD) and those receiving hemodialysis (HD) for end-stage renal disease (ESRD). The study analyzed data from multiple clinical investigations comparing the two dialysis modalities and found that both approaches are equally effective in maintaining patient survival. This suggests that treatment decisions can be tailored based on patient preferences, lifestyle, and clinical suitability rather than concerns about mortality differences.The researchers noted that while overall survival outcomes were similar, certain subgroups showed slight variations. In particular, patients under the age of 65 appeared to have a lower mortality risk with peritoneal dialysis compared to hemodialysis. Regional factors also seemed to influence outcomes, suggesting that differences in healthcare access, dialysis practices, and socioeconomic conditions may play a role in survival trends. Despite these variations, the results indicate that both PD and HD remain viable and effective long-term renal replacement therapies for ESRD patients.The findings underscore the importance of individualized treatment planning in kidney care. Healthcare providers are encouraged to evaluate patient-specific factors such as age, comorbidities, and home support systems before selecting the dialysis modality. The study also highlights the need for improved patient education about both types of dialysis to enable shared decision-making. By focusing on patient comfort, adherence, and quality of life, clinicians can ensure optimal outcomes regardless of the dialysis method chosen.Keywords: peritoneal dialysis, hemodialysis, end-stage renal disease, patient survival, kidney care, renal replacement therapy, BMC NephrologyReference: BMC Nephrology. (2025). Peritoneal and hemodialysis show comparable survival in ESRD, suggests study. BioMed Central. https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-025-04530-4Is
